List of insiders holdings for Processa Pharmaceuticals Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| BESSER JAMES E See Remarks | 2021-05-05 12:53:35 | 405,000 648,300 | 1,053,300 | Form 4/A |
| THOMPSON VIRGIL Director | 2023-07-24 18:33:29 | 118,058 123,849 | 241,907 | Form 4 |
| Floyd Robert Michael Chief Operating Officer | 2023-02-10 17:22:45 | 82,267 89,794 | 172,061 | Form 4 |
| Young David Pres. Research & Development | 2024-04-12 17:01:05 | 99,877 60,315 | 160,192 | Form 4 |
| Baluch Khoso Director | 2023-07-24 18:29:49 | 129,320 0 | 129,320 | Form 4 |
| Neal James R Director | 2023-07-24 18:38:48 | 115,772 0 | 115,772 | Form 4 |
| Pannu Geraldine Director | 2023-10-10 17:05:42 | 57,613 0 | 57,613 | Form 4 |
| Bigora Sian Chief Development Officer | 2024-04-12 16:52:51 | 43,597 6668 | 50,265 | Form 4 |
| Lin Patrick Chief Business - Strategy Off | 2024-04-12 16:55:13 | 48,746 0 | 48,746 | Form 4 |
| Guy Wendy Chief Administrative Officer | 2024-04-12 16:50:41 | 31,565 8335 | 39,900 | Form 4 |
| Yorke Justin W Director | 2024-01-31 16:34:20 | 3737 31,232 | 34,969 | Form 4 |
| Stanker James H Chief Financial Officer | 2024-04-12 16:57:56 | 30,157 0 | 30,157 | Form 4 |
| Ng George K Chief Executive Officer | 2024-01-31 16:37:40 | 0 20,000 | 20,000 | Form 4 |
| Islam Khalid Director | 2022-04-19 21:15:39 | 18,208 0 | 18,208 | Form 4 |